AI prediction models with omics data utilization for atherosclerosis: A systematic scoping review and meta-analysis

Yunbeom Lee1, Kwanwoo Park2, Ji Hyun Lee1

  • 1Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.

Atherosclerosis
|April 20, 2026
PubMed

Insights

Artificial intelligence (AI) prediction models (APMs) significantly outperform conventional risk prediction models (CRMs) for cardiovascular disease. This systematic review highlights AI

Area of Science:

  • Cardiovascular omics research
  • Artificial intelligence in precision medicine
  • High-dimensional data interpretation

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Advanced methods are needed to understand CVD pathophysiology.
  • Artificial intelligence (AI) applied to omics data offers potential for precision medicine.

Purpose of the Study:

  • To systematically review AI technologies in cardiovascular omics research.
  • To compare AI prediction models (APMs) against conventional risk prediction models (CRMs) for atherosclerosis.

Main Methods:

  • Two-phase systematic review: scoping review (218 studies) and meta-analysis (38 studies).
  • Meta-analysis quantified incremental performance of APMs over CRMs using difference in area under the curve (ΔAUC).
  • Focus on atherosclerosis-specific studies.

Main Results:

  • Significant growth observed in AI modeling and omics methodologies.
  • APMs significantly outperformed CRMs (pooled ΔAUC = 0.0586, p < 0.0001).
  • Moderate heterogeneity (I² = 40.02%) observed in meta-analysis.

Conclusions:

  • AI prediction models demonstrate a robust performance advantage over conventional models.
  • Performance benefit of APMs was consistent across various experimental designs and validation strategies.
  • AI holds significant promise for advancing cardiovascular precision medicine through omics data.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
604
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
802
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
607